M. Scott

发表

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

P. Campbell, A. Green, G. Vassiliou, 2005, The Lancet.

Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis

E. Zeggini, W. Ouwehand, M. Quail, 2015, Cell reports.

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.

M. Stratton, P. Futreal, H. Lodish, 2007, The New England journal of medicine.

Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia.

P. Campbell, A. Green, L. Scott, 2006, Blood.

Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells

P. Lehner, P. MacAry, J. Luzio, 2001, Proceedings of the National Academy of Sciences of the United States of America.

AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders

A. Green, M. Dawson, M. Scott, 2010, British journal of haematology.

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability.

L. Campbell, A. Green, A. Bench, 2002, Blood.

Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis

A. Green, W. Erber, A. Bench, 2010, British journal of haematology.

Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis.

M. Scott, J. Compston, D. Bilton, 2006, American journal of respiratory and critical care medicine.

Phospho‐STAT5 and phospho‐Akt expression in chronic myeloproliferative neoplasms

L. Happerfield, W. Erber, A. Bench, 2009, British journal of haematology.

Estrogen stimulates differentiation of megakaryocytes and modulates their expression of estrogen receptors alpha and beta.

M. Scott, J. Compston, J. Craig, 2004, Journal of cellular biochemistry.

A practical strategy for the routine use of BIOMED‐2 PCR assays for detection of B‐ and T‐cell clonality in diagnostic haematopathology

W. Erber, M. Du, A. Bench, 2007, British journal of haematology.

Leukaemia update. Part 2: managing patients with leukaemia in the community

G. Follows, M. Scott, R. Petter, 2013, BMJ : British Medical Journal.

Detection of cytoplasmic nucleophosmin expression by imaging flow cytometry

G. Vassiliou, W. Erber, M. Scott, 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Pitfalls in the Diagnosis of Anaplastic Large Cell Lymphoma with a Small Cell Pattern

G. Follows, M. Scott, P. Wright, 2013, Case reports in hematology.

Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes.

A. Green, P. Fenaux, M. Scott, 1996, Blood.

Microsatellite analysis of posttransplant lymphoproliferative disorders: determination of donor/recipient origin and identification of putative lymphomagenic mechanism.

R. Larson, M. Scott, C. Vnencak-Jones, 1996, Cancer research.

Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.

W. Erber, A. Bench, M. Scott, 2005, Clinical and laboratory haematology.

Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites.

Shane C. Dillon, P. Campbell, I. Dunham, 2006, Genome research.

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

P. Campbell, A. Green, J. Marsden, 2005, The Lancet.

Targeting MEK in vemurafenib-resistant hairy cell leukemia

G. Follows, G. Vassiliou, M. Du, 2018, Leukemia.

W. Erber, A. Bench, M. Scott, 2009, Leukemia.

Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies.

C. Tyler-Smith, Z. Ning, J. Chi, 2016, Blood.

Contribution of immunoglobulin lambda light chain gene rearrangement analysis in the diagnosis of B‐cell neoplasms

M. Du, A. Bench, M. Scott, 2019, British journal of haematology.

Estrogen stimulates differentiation of megakaryocytes and modulates their expression of estrogen receptors α and β

M. Scott, J. Compston, J. Craig, 2004 .

Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib

G. Follows, T. Zenz, A. Bench, 2013, British journal of haematology.

Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone

M. Scott, J. Compston, C. Haworth, 2007, Thorax.

IN SEARCH OF THE HAEMOPOIETIC STEM CELL

M. Scott, M. Gordon, 1995, British journal of haematology.

Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver Cirrhosis

Shahid A. Khan, N. Habib, M. Scott, 2008, The American Journal of Gastroenterology.

Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray

Mike Scott, Michael J Keating, Larissa Belov, 2006, British journal of haematology.

Hairy cell leukemia – immunotargets and therapies

G. Follows, M. Scott, D. Bloxham, 2014, ImmunoTargets and therapy.

High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies

G. Follows, A. Bench, E. Boyd, 2011, British journal of haematology.

infected individuals - Conservation of unique cell-surface CD antigen mosaics in HIV-1

David P. Kreil, W. Gilks, B. Gazzard, 2013 .

HIV-1-infected individuals Conservation of unique cell-surface CD antigen mosaics in

David P. Kreil, W. Gilks, B. Gazzard, 2010 .

Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individuals.

David P. Kreil, W. Gilks, B. Gazzard, 2005, Blood.

Application of growth factor stimulants improves cytogenetic analysis of chronic myeloproliferative disorder patients without alteration to cell lineage or clonality.

M. Scott, E. Nacheva, J. Howard, 2007, Cancer genetics and cytogenetics.

Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen

M. Scott, J. Craig, D. Ireland, 2004, British journal of haematology.

Classification of AML using a monoclonal antibody microarray.

Mike Scott, Larissa Belov, R. Christopherson, 2006, Methods in molecular medicine.

Leukaemia update. Part 1: diagnosis and management

G. Follows, M. Scott, R. Petter, 2013, BMJ.

Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.

M. Scott, J. Compston, J. Craig, 2005, Bone.

TPL-2 MEK kinase is not targeted by mutation in diffuse large B cell lymphoma and myeloid leukemia.

R. Hamoudi, M. Du, A. Bench, 2007, Leukemia research.

KLF 2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and 1 identifies a subset with distinct genotype 2 3

J. Climent, N. Bolli, G. Gundem, 2014 .

JAK2 V617F Mutation Identifies a Biologically Distinct Subtype of Essential Thrombocythemia Which Resembles Polycythemia Vera.

P. Campbell, A. Green, J. Marsden, 2005 .

AT9283, a Potent Inhibitor of JAK2, Is Active in JAK2 V617F Myeloproliferative Disease Models.

A. Green, M. Dawson, M. Scott, 2007 .

Phospho‐STAT5 and phospho‐Akt expression in chronic myeloproliferative neoplasms

L. Happerfield, W. Erber, A. Bench, 2009, British journal of haematology.